SCHEMBL7992234

SCHEMBL7992234

FC(F)Oc1ccc(CCl)cn1

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.52
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
PARP1 P09874 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
PTGES O14684 10/20 0.34
SCN9A Q15858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ACACB O00763 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29738527 1.00 DAO (0.52) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL28959987 0.87 DAO (0.58) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL8008988 0.86 DAO (0.41) DAOHCRTR1HCRTR2
Hydrochloric Acid SCHEMBL28288774 0.85 DAO (0.43) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL7995356 0.84 DAO (0.40) DAOHCRTR1HCRTR2
SCHEMBL16647726 0.81 DAO (0.49) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL30583901 0.81 DAO (0.49) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL4542012 0.81 DAO (0.49) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL4541422 0.81 DAO (0.49) DAOHCRTR1HCRTR2GRIN1GRIN2B
SCHEMBL31143209 0.81 ALDH1A1 (0.45) SCN9AACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055016-B1 GPR52 MODULATOR COMPOUNDS NXERA PHARMA UK LTD (GB) 2026-04-29 EP disclosed
EP-3704094-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-11 EP disclosed
US-20250122188-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2025-04-17 US disclosed
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-05-23 US disclosed
EP-4356971-A2 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2024-04-24 EP disclosed
CN-115947681-A Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2023-04-11 CN disclosed
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2023-01-05 US disclosed
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2023-01-05 US disclosed
US-20220363678-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2022-11-17 US disclosed
CN-109641844-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2022-11-01 CN disclosed
US-5750704-A INSECTICIDES NIHON BAYER AGROCHEM K.K. (JP) 1998-05-12 US disclosed
US-5580889-A Insecticidal nitromethyl or niteoimino-heteromethyl-heterocyclics NIHON BAYER AGROCHEM K.K. (JP) 1996-12-03 US disclosed
US-5461167-A 2-chloro-5-chloromethyl thiazole; insecticide NIHON BAYER AGROCHEM K.K. (JP) 1995-10-24 US disclosed
US-5428032-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1995-06-27 US disclosed
US-5298507-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1994-03-29 US disclosed
US-5204360-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1993-04-20 US disclosed
US-5001138-A Insecticides NIHON TOKUSHU NOYAKU SEIZO, K.K. (JP) 1991-03-19 US disclosed
US-4845106-A INSECTICIDES NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-07-04 US disclosed
US-4742060-A 2-(NITROIMINO)- OR 2-(NITROMETHYLENE)-IMIDAZOLIDINES AS INSECTICIDES NIHON TOKUSHU NOYAKU SEIZO K. K. (JP) 1988-05-03 US disclosed
EP-0192060-A1 Heterocyclic compounds NIHON BAYER AGROCHEM K.K. (JP) 1986-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS GPR52, GPR119, GPR4 DAO 4627/4885HCRTR1 119/4885HCRTR2 44/4885
US-20250122188-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 DAO 4301/4885HCRTR1 2471/4885HCRTR2 2374/4885
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 DAO 4301/4885HCRTR1 2471/4885HCRTR2 2374/4885
US-20220363678-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 DAO 4301/4885HCRTR1 2471/4885HCRTR2 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.